PhyxUp Health, a Korean-founded startup specializing in AI-powered Remote Therapeutic Monitoring (RTM), has secured seed funding from Korea Investment Accelerator and Synergy IB Investment. This funding round follows the company’s pre-seed investment from digital healthcare specialist DHP and global venture capital firm Rabbit VC, marking a strategic follow-on to accelerate market share expansion in the U.S. rehabilitation healthcare market.

Founded by CEO Sangwon Lim, who studied public health at Harvard University and brings clinical experience in rehabilitation, PhyxUp Health is a digital healthcare company headquartered in the United States. The U.S. rehabilitation healthcare market faces structural challenges including low patient adherence, high dropout rates, and excessive administrative burdens. PhyxUp Health addresses these inefficiencies by integrating AI analysis and automation technology to enhance care continuity and treatment quality. The platform analyzes patient health data and exercise performance in real-time to identify risk factors early and support clinical decision-making, earning high praise from American clinicians.

PhyxUp Health has already proven its technology and service reliability by being utilized in hospitals and clinics across the United States, including institutions affiliated with Harvard Medical School. Usage is rapidly growing among diverse customer segments ranging from independent practices to university hospital outpatient centers. With this investment, the company plans to fully launch service expansion centered on major metropolitan areas in the U.S.

Woohyun Nam, team leader at Korea Investment Accelerator who led the investment, stated: “RTM is emerging as a new treatment paradigm, serving as a means to achieve treatment continuity and effective early intervention, alongside expanding CPT code claim volume and coverage. PhyxUp Health is a highly capable team led by Korean professionals, and we expect growth in the evolving U.S. rehabilitation healthcare market.”

Sangwon Lim, CEO of PhyxUp Health, emphasized: “The U.S. rehabilitation healthcare market has significant room for innovation due to high administrative burdens and inefficiencies. Based on this funding, we will advance our AI-powered RTM technology and contribute to rebuilding rehabilitation healthcare infrastructure throughout the United States.”

PhyxUp Health plans to use the funding to expand its global market presence, strengthen its sales force, and develop next-generation products. The company currently supplies two products: one for store refrigeration units and small warehouses (PF105) and another for large distribution centers (PF106). Starting in 2026, the company is preparing to launch models for containers and transport vehicles.